Category: Guest content

India, Intellectual Property and Biotechnology Industry

This is a guest post from BiotechBlog reader Viren Konde. Do you have a response to Viren’s post? If so, you may respond in the comments section below. The recent editorial on “Intellectual property and biotechnology innovation: To protect or not protect” by Dr Yali Friedman, Managing Editor of the Journal of Commercial Biotechnology was […]


Click here for reuse options!
Copyright 2009 Biotechblog

Pfizer’s Power on Individualized Medicine

In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s genome is sequenced and drug prescriptions are based on your genetic makeup, and argues that personalized medicine will be the defining paradigm for discovering and developing drugs of the future. To put these videos into […]


Click here for reuse options!
Copyright 2009 Biotechblog

Pfizer's Power on Individualized Medicine

In these videos Pfizer’s Vice President and Global Head of Molecular Medicine, Aidan Power, talk about a future where everyone’s genome is sequenced and drug prescriptions are based on your genetic makeup, and argues that personalized medicine will be the defining paradigm for discovering and developing drugs of the future. To put these videos into […]


Click here for reuse options!
Copyright 2009 Biotechblog

Naturally Obsessed: The Making of a Scientist

Guest content from Naturally Obsessed Naturally Obsessed: The Making of a Scientist A documentary about careers in science “So what is it that you actually do, Dr. Rifkind?” (groan, groan) It didn’t matter if the question was from my accountant, my dinner party companion or my cousin Minnie, I was never able to give an […]


Click here for reuse options!
Copyright 2009 Biotechblog

Koronis: Developing a new treatment for HIV

I recently had the opportunity to conduct a brief interview with Jeff Parkins, Vice President of Clinical Development and Regulatory at Koronis on his company and the future of the biotechnology industry: Can you tell me a little bit about Koronis and its mission? Koronis Pharmaceuticals develops anti-viral therapeutics based on Viral Decay Acceleration TM […]


Click here for reuse options!
Copyright 2009 Biotechblog

Biotechnology Management Papers

These papers are from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons biotechnology company management: Financial opportunities for early stage biotech companies Tamara Jones The […]


Click here for reuse options!
Copyright 2009 Biotechblog

The changing roles of CRO

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. The changing roles of CRO Alex Bao […]


Click here for reuse options!
Copyright 2009 Biotechblog

Discovering potential drug targets

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Discovering potential drug targets Myung K. Kim […]


Click here for reuse options!
Copyright 2009 Biotechblog

Financial opportunities for early stage biotech companies

This is a student paper from the 2009 final projects in the NIH Foundation for Advanced Education in the Sciences’ TECH 366 — Biotechnology Management. The students were asked to tell a story based on the course lectures, and to expand with general lessons on biotechnology company management. Financial opportunities for early stage biotech companies […]


Click here for reuse options!
Copyright 2009 Biotechblog

Solving the FDA Crisis

Guest content from John Avellanet, managing director and principal of Cerulean Associates: Solving the FDA Crisis By John Avellanet, Managing Director and Principal of Cerulean Associates LLC News of the latest crisis under the FDA’s watch – salmonella contamination and the peanut plant in Georgia – has all the usual suspects calling for increased inspections […]


Click here for reuse options!
Copyright 2009 Biotechblog

%d bloggers like this: